Equipoise Therapeutics

AgaMatrix is a consumer medical device company that develops and manufactures blood glucose monitoring products for the diabetes market. The company s products feature WaveSense, a technology that personalizes each test to provide accuracy. WaveSense detects and corrects several errors that are caused by differences in blood samples and environmental conditions. Zero-Click, a diabetes data management system from WaveSense, simplifies data download. WaveSense and Zero-Click consist of six Food & Drug Administration-cleared products and are protected by a suite of more than 160 patents worldwide. AgaMatrix offers products under the KeyNote, KeyNote Pro and Presto brand names.

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Epizyme, Inc is a global biopharmaceutical leader focused on developing innovative medicines in oncology, neuroscience, and rare diseases. The company is dedicated to improving lives through cutting-edge research and the development of transformative therapies. Generated from their website's infomation